Status:
UNKNOWN
Effect of Percutaneous Botulinum Toxin A Injection on Natural Course of Upper Lid Retraction in Thyroid Eye Disease
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Eye Diseases
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
In active phase of thyroid eye disease some patients have obvious upper lid retraction , and sometimes exposure keratopathy .To date there is not any standard treatment for this situation . We are goi...
Eligibility Criteria
Inclusion
- all the patients wiht oper lid retraction in active phase of thyroid ophthalmopathy
Exclusion
- patients in non active phase
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
February 1 2007
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00370734
Start Date
May 1 2005
End Date
February 1 2007
Last Update
February 27 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Babak Babsharif, MD
Tehran, Tehran Province, Iran, 16666